Clinical Trials in New York

Showing 5041-5060 of 22,668 trials

Imaging With a PET Agent for Detection of Cancers of the Head and Neck

NCT03631017

The purpose of this study is to test the safety of a study drug called PARPi-FL. This drug has been tested in animals but not yet in people. The purpose of this study is to test if a PARPi-FL scan can be used to take pictures of head and neck cancer. The usual approach to imaging this cancer includes several different imaging scans, including x-rays, CT (computed tomography), MRI (magnetic resonance imaging), and PET (positron emission tomography). These tests take pictures of the cancer.

Head and Neck Cancer

Memorial Sloan Kettering Cancer Center12 participantsStarted Aug 2018

New York, New York, United States

Active Not Recruiting< 1 mile

Prostate-Specific Membrane Antigen (PSMA) PET Scans in People Prostate Cancer

NCT04030338

The purpose of this study is to determine if Prostate-Specific Membrane Antigen (PSMA) positron emission tomography (PET) scans used in this study accurate and better at imaging participants' prostate cancer than the usual methods.

Prostate CancerProstate NeoplasmProstate Adenocarcinoma+2 more

Memorial Sloan Kettering Cancer Center58 participantsStarted Jul 2019

Basking Ridge, New Jersey, United States • Middletown, New Jersey, United States • Montvale, New Jersey, United States +4 more locations

Imaging With a PET Agent for Detection of Cancers of the Head and Neck

Prostate-Specific Membrane Antigen (PSMA) PET Scans in People Prostate Cancer

Find Trials by Condition in New York

A Study of Adjuvant Intismeran Autogene (V940) and Pembrolizumab in Renal Cell Carcinoma (V940-004).

A Study of Abemaciclib in Recurrent Glioblastoma

INSPIRIS RESILIA Aortic Valve, Valve-in-Valve Surveillance Study

The LATITUDE Study: Long-Acting Therapy to Improve Treatment SUccess in Daily LifE

Neurocognitive Factors in EdTech Intervention Response

Optimal Dosing of High-Intensity Locomotor Training for Step Attainment and Locomotor Outcomes in Stroke Patients Undergoing Acute Inpatient Rehabilitation

CorMatrix Cor TRICUSPID ECM Valve Replacement - Pivotal Study

Safety and Tolerability Study of Daily Dosing Rimegepant in Episodic Migraine Prevention

Phase 2 Study of Rivaroxaban Reversal by Ciraparantag as Measured by WBCT

Phase 2 Study of Apixaban Reversal by Ciraparantag as Measured by WBCT

A Study to Test Whether Two Different Doses of Avenciguat Help People With Liver Cirrhosis and High Blood Pressure in the Portal Vein (Main Vessel Going to the Liver)

Testing the Effects of Methylphenidate on Multiple Sclerosis

To Assess the Safety, Tolerability and Efficacy of Itacitinib Immediate Release Tablets in Participants With Primary or Secondary Myelofibrosis Who Have Received Prior Ruxolitinib and/or Fedratinib Monotherapy (LIMBER-213)

Randomized Controlled Physical Activity App Intervention for Black Women

A Phase IIb, Randomized, Double-Blind, Placebo-Controlled Study of Elismetrep (K-304) in the Treatment of Migraine

MR Image Synthesis With Low Gadobutrol Dose and AI

A Study of Two Different Doses of Cabozantinib (XL184) in Progressive, Metastatic Medullary Thyroid Cancer

Sub-study of Belantamab Mafodotin (GSK2857916) as Monotherapy and in Combination With Nirogacestat, Pomalidomide, and Dexamethasone in Participants With RRMM